CPT code 68100 represents a conjunctival biopsy, a diagnostic surgical procedure to obtain conjunctival tissue for histologic or cytologic evaluation. This code is relevant nationally for ophthalmology practices, ambulatory surgical centers, and hospital outpatient departments because conjunctival biopsy can be essential for diagnosing inflammatory, infectious, and neoplastic conditions of the ocular surface.

Key payers in the scope of national reimbursement and policy discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for use of the code, typical settings where the procedure is performed, and the payer landscape addressed in the publication. The analysis highlights common billing considerations, coding and documentation touchpoints, and benchmark metrics where available. Policy updates and payer-specific coverage nuances affecting prior authorization and claim adjudication are summarized to inform billing staff and revenue-cycle stakeholders.

The report is written for a national audience and focuses on practical information for billing, clinical teams, and policy analysts seeking concise guidance on the role and billing context of CPT code 68100. Data not available in the input is noted where applicable.